Variable | |
---|---|
Median age, years (range) | 73 (47-89) |
Biopsy Gleason score, n (%) | |
<8 | 16 (23.8%) |
≥8 | 50 (73.6%) |
NA | 1 (1.4%) |
Median PSA at pretreatment, ng/mL (range) | 14.2 (0.224-8214) |
Clinical stage at diagnosis, n (%) | |
N0M0 | 31 (46.2%) |
N1M0 | 4 (5.9%) |
M1 | 32 (47.7%) |
Prior docetaxel | 23 (34.3%) |
Prior abiraterone | 8 (11.9%) |
Corticosteroid administration | 18 (26.8%) |
Median psoas muscle ratio, cm3/m (range) | 160.1 (87.3-240.1) |
Median visceral fat, % (range) | 36.4 (11.1-58.3) |
Median body fat, % (range) | 34.5 (12.3-51.5) |
Median V/S ratio, ratio (range) | 1.04 (0.46-2.12) |
Fatigue (gradea,b) | |
0 | 36 (53.7%) |
1 | 19 (28.3%) |
2 | 10 (14.9%) |
3 | 2 (2.9%) |
Anorexia (grade) | |
0 | 44 (65.6%) |
1 | 13 (19.4%) |
2 | 7 (10.4%) |
3 | 3 (4.4%) |
4 | 0 |
5 | 0 |
Pain (grade) | |
0 | 54 (80.5%) |
1 | 6 (8.9%) |
2 | 2 (2.9%) |
3 | 5 (7.4%) |
Insomnia (grade) | |
0 | 63 (94.0%) |
1 | 3 (4.4%) |
2 | 1 (1.4%) |
3 | 0 |
Parameter | Fatigue (>G2) | Anorexia (>G2) | Pain (>G2) | Insomnia (>G1) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | |
Age | 1.012 | 0.939-1.091 | 0.744 | 1.075 | 0.984-1.176 | 0.108 | 0.942 | 0.858-1.033 | 0.208 | 1.018 | 0.901-1.151 | 0.765 |
Prior docetaxel | ||||||||||||
− | 1 | 1 | 1 | 1 | ||||||||
+ | 0.947 | 0.252-3.555 | 0.936 | 0.792 | 0.184-3.406 | 0.755 | 2.877 | 0.585-14.147 | 0.193 | 0.621 | 0.060-6.331 | 0.678 |
Corticosteroid | ||||||||||||
− | 1 | 1 | 1 | 1 | ||||||||
+ | 0.487 | 0.095-2.477 | 0.386 | 2.047 | 0.504-8.316 | 0.316 | 2.25 | 0.451-11.222 | 0.326 | 0.901 | 0.087-9.275 | 0.93 |
Psoas muscle ratio | ||||||||||||
<160.1 | 1 | 1 | 1 | 1 | ||||||||
≥160.1 | 3.875 | 1.016-17.134 | 0.047 | 0.093 | 0.011-0.784 | 0.029 | 0.801 | 0.165-3.893 | 0.784 | 1.099 | 0.145-8.303 | 0.924 |
Body fat | ||||||||||||
<34.5 | 1 | 1 | 1 | 1 | ||||||||
≥34.5 | 2.074 | 0.558-7.698 | 0.275 | 0.559 | 0.142-2.196 | 0.405 | 1.247 | 0.256-6.057 | 0.784 | 2.906 | 0.286-29.468 | 0.366 |
Visceral fat | ||||||||||||
<36.4 | 1 | 1 | 1 | 1 | ||||||||
≥36.4 | 2.230 | 0.600-8.282 | 0.230 | 0.600 | 0.152-2.356 | 0.464 | 0.701 | 0.144-3.407 | 0.660 | 3.096 | 0.305-31.399 | 0.338 |
V/S ratio | ||||||||||||
<1.04 | 1 | 1 | 1 | 1 | ||||||||
≥1.04 | 1.350 | 00381-4.776 | 0.641 | 4.444 | 0.866-22.783 | 0.073 | 0.327 | 0.058-1.821 | 0.202 | 2.906 | 0.286-29.468 | 0.366 |
Psoas muscle ratio | |||
---|---|---|---|
Parameter | <160.1 | ≥160.1 | P value |
Median age (range) | 72 (47-87) | 68 (55-89) | 0.028 |
Prior docetaxel | 13 (19.4) | 10 (14.9) | 0.611 |
Prior abiraterone | 6 (8.9) | 2 (2.9) | 0.169 |
Corticosteroid administration | 10 (14.9) | 8 (11.9) | 0.741 |
Median body fat (range) | 31.7 (12.3-49.8) | 37.1 (22.2-51.5) | 0.002 |
Median visceral fat (range) | 31.8 (11.1-58.3) | 39.9 (18.3-55.8) | 0.001 |
Median V/S ratio (range) | 0.96 (0.46-1.97) | 1.15 (0.58-2.12) | 0.118 |